HOME > MARKETS > ECONOMY NEWS
  ECONOMY NEWS
ECONOMY
India's pharma exports remain resilient in H1 FY27 with growth of 5%: Pharmexcil
Oct-30-2026

The Pharmaceuticals Export Promotion Council of India (Pharmexcil) in its latest data report has showed that India's pharmaceutical export sector maintained its growth momentum in the first half of the current fiscal year (H1 FY27), with overseas shipments rising nearly 5 per cent year-on-year to $16.13 billion from $15.38 billion in the same period last fiscal year. Strong demand from key international markets, particularly Europe, ASEAN and Latin America, supported the expansion. 

The report added that the first-half performance saw growth across drug formulations and biologicals, bulk drugs and drug intermediates, and surgical products. Region-wise, exports to Europe rose 9.66 per cent to $3,288.27 million, making up 20.38 per cent or over one-fifth of India's total pharmaceutical exports during H1 FY27.

Further, exports to the ASEAN region grew 21.54 per cent, Latin America and the Caribbean rose 16.58 per cent, and shipments to Africa increased 6.48 per cent. Pharmexcil said these diversified geographic gains helped sustain overall export growth even as shipments to the US moderated during the period. On the product front, drug formulations and biologicals remained the largest export segment, accounting for 73.84 per cent of total shipments and growing 3.81 per cent. Bulk drugs and drug intermediates rose 12.07 per cent, while surgical exports climbed 9.53 per cent.


  RELATED NEWS >>